NCT07349940 2026-03-27
MEL
Institute of Health Information and Statistics of the Czech Republic
Phase NA Recruiting
Clinical Trials
24 trialsNCT07349303 2026-01-21
NEOPRIME
Vastra Gotaland Region
Phase 2 Recruiting
NCT04812470 2025-09-22
HAITILS
Vastra Gotaland Region
Phase 1 Completed
NCT07183852 2025-09-19
GoTIL-01
Vastra Gotaland Region
Phase 1 Not yet recruiting
NCT05304546 2025-07-22
MK3475-C01
Sheba Medical Center
Phase 2 Completed
NCT06363591 2025-03-05
WoW
Vastra Gotaland Region
Phase NA Recruiting
NCT06670300 2024-11-01
Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer
Henan Cancer Hospital
Phase 2 Not yet recruiting
NCT04924413 2024-07-03
L-TIL Plus Tislelizumab as First-line Treatment in Advanced Malignant Melanoma
Henan Cancer Hospital
Phase 2 Terminated
NCT03685890 2024-04-25
NivoILP
Vastra Gotaland Region
Phase 1/2 Recruiting
NCT04460053 2024-04-24
ILP-NfL
Vastra Gotaland Region
Phase NA Completed
NCT01785316 2024-01-26
SCANDIUM
Vastra Gotaland Region
Phase 3 Completed
NCT03073304 2024-01-26
ILP-Prime
Vastra Gotaland Region
Phase NA Completed
NCT04242329 2024-01-26
SUMMIST
Vastra Gotaland Region
Phase 2 Withdrawn
NCT05990634 2023-08-14
LifeChamps Feasibility Study
Region Stockholm
Phase NA Unknown
NCT05928962 2023-07-10
An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas
Fujian Cancer Hospital
Phase 1 Unknown
NCT05903937 2023-06-15
HAITILS-PHP
Vastra Gotaland Region
Phase 1 Not yet recruiting
NCT05664139 2023-02-08
Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma
Fujian Cancer Hospital
Phase 2 Unknown
NCT03166397 2023-01-26
Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients
Sheba Medical Center
Phase 2 Recruiting
NCT04142931 2021-03-24
Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors
Sheba Medical Center
Phase 1 Unknown
NCT04507048 2020-12-02
PAMela
Azienda USL Reggio Emilia - IRCCS
Phase NA Completed
NCT03353402 2019-04-03
Fecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed Immunotherapy
Sheba Medical Center
Phase 1 Unknown
NCT03383237 2017-12-27
Clinical Study of Apatinib as the Second-line Therapy in Malignant Melanoma
Henan Cancer Hospital
Phase 2 Unknown
NCT00287131 2012-03-29
Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients
Sheba Medical Center
Phase 2 Unknown
NCT00111046 2005-11-10
Pain Relief - Tramadol Versus Ibuprofen
Royal Liverpool University Hospital
Phase 1/2 Unknown